Skip to main content

Table 1 Clinicopathological and therapeutic features of patients who underwent duodenopancreatectomy

From: Does intraoperative closed-suction drainage influence the rate of pancreatic fistula after pancreaticoduodenectomy?

Characteristics Study population
(n = 197)
Passive drainage
(n = 132)
Closed-suction drainage
(n = 65)
 
  No./mean ± SDa (%) No./mean ± SDa (%) No./mean ± SDa (%) p
Age (years) 66.2 ± 11.8 - 64.8 ± 11.3 - 68.5 ± 11.8 - 0.08
Male 108 (54.8) 70 (53.0) 38 (58.5) 0.47
Body mass index (kg/m2) 25.0 ± 4.3 - 24.7 ± 4.1 - 25.5 ± 4.4 - 0.21
ASAb score 0.31
 1 44 (22.3) 34 (25.0) 10 (15.4)
 2 114 (57.9) 75 (56.8) 39 (60.0)
 3 39 (18.3) 23 (17.4) 16 (24.6)
Chronic pancreatitis 30 (19.8) 19 (14.4) 12 (18.5) 0.46
Pathology <0.01
 Adenocarcinoma 134 (68.0) 97 (73.5) 37 (56.9)
 Cholangiocarcinoma 7 (3.6) 6 (4.5) 1 (1.5)
 Ampullocarcinoma 6 (3.0) 5 (3.8) 1 (1.5)
 Other 50 (25.4) 24 (18.2) 26 (40.1)
Neoadjuvant treatment 22 (11.2) 13 (9.8) 9 (13.8) 0.40
Pre-operative biliary drainage 93 (47.2) 66 (50.0) 27 (41.5) 0.26
Artery resection 1 (0.5) 1 (0.8) 0 (0) 1.00
Vein resection 38 (19.3) 32 (24.2) 6 (9.2) 0.01
Pylorus preservation 142 (72.1) 106 (80.3) 36 (55.4) <0.01
Type of pancreatic anastomosis <0.01
 Pancreaticogastrostomy 97 (49.2) 79 (60.3) 18 (28.1)
 Pancreaticojejunostomy 98 (49.8) 52 (39.7) 46 (71.9)
Soft pancreatic gland texture 28 (14.2) 18 (13.6) 10 (15.4) 0.66
Main pancreatic duct diameter 4.93 ± 2.45 - 5.0 ± 2.3 - 5.1 ± 2.7 - 0.79
Intra-operative blood loss (mL) 685 ± 588 - 664 ± 519 - 728 ± 719 - 0.89
Blood transfusion 44 (22.3) 28 (22.8) 16 (24.6) 0.78
Operative time (minutes) 388 ± 125 - 339 ± 136 - 377 ± 95 - 0.16
Somatostatin analogs 89 45.2 61 47.3 28 43.7 0.65
  1. aStandard deviation
  2. bAmerican Society of Anesthesiology